Pmltm2.1Ppp
Targeted Allele Detail
|
|
| Symbol: |
Pmltm2.1Ppp |
| Name: |
promyelocytic leukemia; targeted mutation 2.1, Pier P Pandolfi |
| MGI ID: |
MGI:6155604 |
| Synonyms: |
Pmlflox |
| Gene: |
Pml Location: Chr9:58125359-58157069 bp, - strand Genetic Position: Chr9, 31.63 cM
|
| Alliance: |
Pmltm2.1Ppp page
|
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:260988
|
| Parent Cell Line: |
Not Specified (ES Cell)
|
| Strain of Origin: |
Not Specified
|
|
| Allele Type: |
|
Targeted (Conditional ready, No functional change) |
| Mutation: |
|
Insertion
|
| |
|
Mutation details: A loxP site was inserted upstream of exon 2. An FRT-flanked neomycin resistance cassette with a 3' loxP site was inserted downstream of exon 2. Flp-mediated recombination removed the selection cassette and left exon 2 floxed.
(J:260988)
|
|
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Pml Mutation: |
92 strains or lines available
|
|
| Original: |
J:260988 Chen M, et al., An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer. Nat Genet. 2018 Feb;50(2):206-218 |
| All: |
2 reference(s) |
|